A Brief Review of Pharmacotherapies for Smoking Cessation

2006 ◽  
Vol 4 (6) ◽  
pp. 583-589 ◽  
Author(s):  
Cho Y. Lam ◽  
Jennifer A. Minnix ◽  
Jason D. Robinson ◽  
Paul M. Cinciripini

The U.S. Department of Health and Human Services' Clinical Practice Guidelines have established both nicotine and nonnicotine-based pharmacotherapies as efficacious treatments for smoking cessation. Smokers attempting to quit smoking can significantly increase their chances by using one of several first-line agents, including nicotine transdermal patches, gum, nasal spray, inhalers, tablets, and the antidepressant bupropion. Those who cannot use either bupropion or nicotine replacement therapy because of contraindications or lack of effectiveness may benefit from the second-line treatment nortriptyline. This article also discusses several novel compounds for smoking cessation.

Author(s):  
Kelsie Cowman ◽  
Yi Guo ◽  
Liise-anne Pirofski ◽  
David Wong ◽  
Hongkai Bao ◽  
...  

Abstract We partnered with the U.S. Department of Health and Human Services to treat high-risk, non-admitted COVID-19 patients with bamlanivimab in the Bronx, NY per Emergency Use Authorization criteria. Increasing post-treatment hospitalizations were observed monthly between December 2020-March 2021 in parallel to the emergence of SARS-CoV-2 variants in New York City.


HPHR Journal ◽  
2014 ◽  
Vol 2014 (1) ◽  
Author(s):  
Benjamin D. Sommers ◽  

The first open enrollment period under the Affordable Care Act has come and gone. One might be tempted to ask, “How has the law done so far?” — if only that question hadn’t already been asked ad nauseum since the first week of open enrollment in October 2013. As a researcher whose primary interests are insurance coverage and access to care (and as an advisor in the U.S. Department of Health and Human Services), I have frequently been asked this question – by students, by friends and family, and by reporters. Consider this my response.


Author(s):  
Saira Ajmal ◽  
Zelalem Temesgen

Upon completion of this chapter, the reader should be able to • Discuss categories of regimens for first-line antiretroviral therapy. • Recognize the basis for the US Department of Health and Human Services (USDHHS) guidelines for initial antiretroviral therapy. • Recognize and apply recommended regimens for initiation of antiretroviral therapy....


2021 ◽  
Author(s):  
Kate Hubbard ◽  
David Huang

This report provides a quantitative end-of-decade assessment of the nation’s progress toward achieving health goals set by the U.S. Department of Health and Human Services.


Sign in / Sign up

Export Citation Format

Share Document